The Green Organic Dutchman Ltd. Receives Sales License From Health Canada

HAMILTON, ON--(Marketwired - August 24, 2017) - The Green Organic Dutchman Holdings Ltd. ("TGODH") is pleased to announce that its wholly-owned subsidiary, The Green Organic Dutchman Ltd. ("TGOD" or the "Company"), has been granted a sales license from Health Canada to sell medicinal cannabis to other Licensed Producers pursuant to the Access to Cannabis for Medical Purposes Regulations ("ACMPR").

Csaba Reider, President of TGODH, commented, "The granting of a wholesale license allows us the ability of generating revenue almost immediately for our shareholders. This is a crucial step as we continue to drive our business plan forward, and prepare for the recreational market in Canada."

Since receiving our Cultivation License in August of 2016, the Company has received numerous requests from other licensed producers related to the wholesale of our organic and pesticide-free product. Patients seeking such high-quality product, provided by a company focused on responsible and sustainable practices, now have a Licensed Producer who truly understands their needs.

ABOUT THE GREEN ORGANIC DUTCHMAN LTD.

The Green Organic Dutchman Ltd. grows high quality, organically grown, pesticide free medical cannabis in small batches using craft growing, all-natural principles. TGOD's. products are laboratory tested to ensure patients have access to a standardized, safe and consistent product.

The Green Organic Dutchman Ltd. has a funded capacity of 14,000KG's. Situated on 100 acres of land, this gives TGOD one of the largest licensed land parcels in Canada. To date, the Company has raised $41.5 million dollars and has over 2,400 shareholders.

The Green Organic Dutchman Ltd. is licensed under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") to cultivate medical cannabis. The Green Organic Dutchman Ltd. carries out its principal activities producing cannabis from its facilities in Hamilton, Ontario, pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors -- including the availability of funds, the results of financing efforts and the parties' due diligence reviews, and general market conditions -- that could cause actual results to differ materially from the Company's expectations. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.